The EMBARC European Bronchiectasis Registry: protocol for an international observational study

J.D. Chalmers, S. Aliberti, E. Polverino, M. Vendrell, M. Crichton, M. Loebinger, K. Dimakou, I. Clifton, M. van der Eerden, Gernot Rohde, M. Murris-Espin, S. Masefield, E. Gerada, M. Shteinberg, F. Ringshausen, C. Haworth, Wim Boersma, J. Rademacher, A.T. Hill, T. AksamitA. O’Donnell, L. Morgan, Branislava Milenkovic, L. Tramma, J. Neves, R. Menendez, P. Paggiaro, V. Botnaru, S. Skrgat, R. Wilson, P. Goeminne, A. De Soyza, Tobias Welte, Antoni Torres, J. Stuart Elborn, Francesco Blasi

Research output: Contribution to journalArticleAcademicpeer-review


Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no approved therapies and few large-scale, representative epidemiological studies. The EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) registry is a prospective, pan-European observational study of patients with bronchiectasis. The inclusion criterion is a primary clinical diagnosis of bronchiectasis consisting of: 1) a clinical history consistent with bronchiectasis; and 2) computed tomography demonstrating bronchiectasis. Core exclusion criteria are: 1) bronchiectasis due to known cystic fibrosis; 2) age
Original languageEnglish
Article number00081-2015
JournalERJ Open Research
Issue number1
Publication statusPublished - 2016


Dive into the research topics of 'The EMBARC European Bronchiectasis Registry: protocol for an international observational study'. Together they form a unique fingerprint.

Cite this